Kris Jenner
Partner @ Rock Springs Capital
Annapolis, United States
Kris Jenner is a Series A investor at Rock Springs Capital in Annapolis focused on Biotechnology and Medical. Kris Harland Jenner is based out of Annapolis, Maryland and is a Partner of Rock Springs Capital. Kris Harland Jenner previously worked at T. Rowe Price Group, Inc., and T. Rowe Price Associates, Inc. as a vice president. Kris Harland Jenner attended the University of Illinois.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Kris Jenner invests in
Stages Kris Jenner invests in
Countries Kris Jenner invests in
Investment Focus
Industry
- Biotechnology 3 (50%)
- Medical 2 (33%)
- Health Care 2 (33%)
- Apps 1 (17%)
- Religion 1 (17%)
Stage
- Series A 2 (33%)
- Seed 1 (17%)
- Series B 1 (17%)
- Series C 1 (17%)
- Funding Round 1 (17%)
Country
- United States 4 (67%)
- United Kingdom 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
GammaTime
|
GammaTime uses predictive AI and audience testing to ensure that each piece of content increases viewer engagement and happiness. | $14M / Seed / Oct 23, 2025 | |
Genesis Molecular AI
|
Their academia-leading research was the initial component of our expanding portfolio of AI technologies. They are combining novel deep neural networks, biophysical simulation, and massively scalable computing infrastructure to achieve industry-leading performance in a molecular generation and property prediction.The company was founded in 2019and based in South San Francisco, California. | $200M / Series B / Aug 21, 2023 | |
Glorify
|
Glorify is a Christian Daily Worship and well-being app designed to strengthen a user's relationship with God through bite-sized daily devotionals, a library full of meditations, declarations, prayers and exclusive music, and much more. | $40M / Series A / Dec 02, 2021 | |
Affinivax
|
Affinivax is a biopharmaceutical company developing vaccines used to enhance the depth of protection against infectious diseases.This novel and highly efficient vaccine conjugation technology – named MAPS for Multiple Antigen Presenting System – has the potential to deliver novel vaccines that offer broader disease coverage than existingvaccines, as well as protect against infectious diseases for which there are no effective immunization strategies today.The company is rapidly advancing a lead program targeting Streptococcus pneumoniae (pneumococcus), a pathogen that is responsible for significant morbidity and mortality in children and adults worldwide. Affinivax was established based on the knowledge and insights of world-leading experts in the fields of infectious diseases and vaccines. The company is backed by an investment from the Bill & Melinda Gates Foundation and has an exclusive license from Boston Children’s Hospital for intellectual property related to the MAPS technology platform. | $226M / Series C / Jan 08, 2021 | |
|
Genesis Molecular AI
|
Their academia-leading research was the initial component of our expanding portfolio of AI technologies. They are combining novel deep neural networks, biophysical simulation, and massively scalable computing infrastructure to achieve industry-leading performance in a molecular generation and property prediction.The company was founded in 2019and based in South San Francisco, California. | $52M / Series A / Dec 02, 2020 | |
Flame Biosciences
|
Flame Biosciences is a clinical-stage company developing value-added medicines in the emerging area of inflammasome science. The company focuses on the research, development, and commercialization of transformative therapies for cancer and other inflammatory conditions. It was founded in 2017 and headquartered in New York, United States. | $100M / Sep 30, 2020 |
Co-Investors
About Rock Springs Capital
Rock Springs Capital is an investment company located in Baltimore, Maryland. Its advisory activities include management services to security portfolios and portfolio management for businesses or institutional clients.
Rock Springs Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Kris Jenner
Partner
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Kris Jenner invest in?
Kris Jenner invests primarily in Biotechnology, Medical and Health Care startups, most often at Series A and Seed stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Kris Jenner last invest?
The most recent investment recorded for Kris Jenner closed in Oct 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
